# Aberrant Expression of Micro RNA for Diagnosis of Breast Cancer

> **NCT04720508** · — · UNKNOWN · sponsor: **Assiut University** · enrollment: 50 (estimated)

## Conditions studied

- Breast Cancer

## Interventions

- **DIAGNOSTIC_TEST:** blood sample collection.

## Key facts

- **NCT ID:** NCT04720508
- **Lead sponsor:** Assiut University
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2021-12-01
- **Primary completion:** 2023-10-25
- **Final completion:** 2023-12-25
- **Target enrollment:** 50 (ESTIMATED)
- **Last updated:** 2021-01-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04720508

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04720508, "Aberrant Expression of Micro RNA for Diagnosis of Breast Cancer". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT04720508. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*